MARKET EYE-Stay cyclically and aggressively positioned in 2013-Citi

Fri Nov 30, 2012 2:49pm IST

Related Topics

Stocks

   

* India in 2013 will be cacophonous; a mix of politics,
impending elections, reforms and economic revival expectations,
Citigroup said in report.
* The investment bank expects India's benchmark index 
to reach 20,800 by December 2013, based on premise of 9.6/12
percent earnings growth for FY13/FY14 and a valuation multiple
of 14.5 times - a slight discount to its 15-16 times longer-term
average. 
* Citi says the cyclical/risk trade that worked in 2012 should
continue to be the preferred one for 2013, thereby maintaining
its 'overweight' stance on banks, consumer discretionary,
capital goods, IT stocks, while raising telecom to 'overweight'
as well. 
* The bank remains 'underweight' on consumer staples, utilities,
energy and materials. 
* Citi prefers Axis Bank, ICICI Bank,
Infosys, Maruti Suzuki India and Bharti
Airtel among large-cap stocks, while its midcap top
picks are Apollo Hospitals Enterprise, Idea Cellular
, Sun TV, LIC Housing Finance and
Exide Industries.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
FILED UNDER:

"India's Daughter"

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage